Effect of inhibition of angiotensin converting enzyme by ramipril and aminopeptidase P by 2-mercaptoethanol in rats with experimental myocardial infarction

Indian Journal of Pharmacology

Volumn 33, Issue 2, 2001, Pages 72-76

  Annapurna, A ^a   Krishna Kumar, V ^b  

^a ANDHRA UNIVERSITY   (India)

^b Cheruvu Bazaar   (India)

Author keywords

ACE inhibitor; APP inhibitor; Bradykinin; Myocardial infarction

Indexed keywords

AMINOPEPTIDASE P; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; FREE RADICAL; LIPID; MALONALDEHYDE; MERCAPTOETHANOL; RAMIPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONARY REPERFUSION; DRUG EFFECT; ELECTROCARDIOGRAM; ENZYME INHIBITION; EXPERIMENTAL RAT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART MUSCLE NECROSIS; HEART PROTECTION; IN VIVO STUDY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPID PEROXIDATION; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT; STAIN; SYSTOLIC TIME INTERVAL;

EID: 0035039629     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Yogesh T, Hegde BM. Effect of α - tocopherol pretreatment on infarct size following 90 minutes of ischemia and 4 hours of reperfusion in dogs. Indian J Physiol Pharmacol 1997;41:241-7.
2. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976;15:212-6.
3. Barar FSK, Essentials of pharmacotherapeutics. 3rd ed., New Delhi: S. Chand and Company Ltd, 2000.
4. Cobbaert C, Hermens WT, Kint PP, Klootwijk PJ, Van De Werf F, Simoons ML. Thrombolysis induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins. Cardiovas Res 1997;33:147-55.
5. Granger CB. Adenosine for myocardial protection in acute myocardial infarction. Am J Cardiol 1997;79:44-8.
6. Juggi JS, Koenig Berard E, Vanglist WH. Cardioprotection by ACE inhibitors. Can J Cardiol 1993;9:336-52.
7. Heusch G, Rose J, Ehring T. Cardioprotection by ACE inhibitors in myocardial ischemia- reperfusion. The importance of bradykinin. Drugs 1997;54:31-41.
8. Remme WJ. Bradykinin - mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti ischemic therapy. Drugs 1997;54:59-70.
9. Young JB. Reduction of ischemic events with ACE inhibitors: lessons and controversy emerging from recent clinical trials. Cardiovasc Drugs Ther 1995;9:89-102.
10. Przyklenk K, Kloner RA. "Cardioprotection" by ACE inhibitors in acute myocardial ischemia and infarction. Basic Res Cardiol 1993;88:139-54
11. Armapurna A, Rajendra Babu M, Ranganayakulu D. Cardioprotective actions of enalapril and lisinopril on ischema - reperfusion induced myocardial infarction in normal and salt loaded rats. Indian J Pharmacol 2000;32:202-5.
12. Zanzinger J, Zheng H, Bassenge E. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res 1994;2:209-14.
13. Dendorfer A, Wolfrum P, Well honer P, Korsman K, Dominiak P. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. Br J Pharmacology 1997, 122:1179-87.
14. Alabaster VA, Bakhle YS. Bradykininase activities of extracts of dog lung. Br J Pharmacol 1973;47:799-807.
15. Orawski AT, Surz JP, Simmons WH. Metabolism of bradykinin by multiple co existing membrane bound peptidases in lung : Techniques for investigating the role of each peptidase using specific inhibitors. Adv Exp Med Biol 1989; 247B:355-64.
16. Prechel MM, Orawski AT, Maggiora LL, Simmons WH, Effect of a new aminopeptidase P inhibitor apstatin, on bradykinin degradation in the rat lung. J Pharmacol Exp Ther 1995;275:1136-42.
17. Johnston CI, Clappison BH, Anderson WP, Yasujima M. Effect of ACE inhibition on circulating and local kinin levels. Am J Cardiol 1982;49:1401-4.
18. Furchgott RF, Vanhoutte PM. Endothelium derived relaxing and contracting factors. FASEB 1989;3:2007-18.
19. Brunner F, Kukovetz WR. Post ischemic antiarrythmic effects of ACE inhibitors. Circulation 1996;94:1752-61.
20. Rump AF, Koreuber D, Roesen R, Klaus W. Cardioprotection by ramiprilat in isolated rabbit hearts. Eur J Pharmacol 1993;241:201-7.
21. Bishopl JE, Kiernani LA, Montgomery HE, Gohlke P, Mc E, Wan JR. Raised blood pressure, not renin - angiotensin systems, causes cardiac fibrosis in TGR m (Ren 2) 27 rats. Cardiovasc Res 2000;47:57-67.
22. Martorana PA, Sch Olkens BA. The possible role of bradykinin in the anti ischemic activity of ACE - inhibitors. Agents Actions Suppl 1992;39 (pt-3):98-102.
23. Gonzalez W, Beslot F, Laboulandine I, Zaluski MCF, Roques BP, Michel JB. Inhibition of both ACE and NEP by S21402 (RB105) in rats with experimental myocardial infarction. J Pharmacol Exp Ther 1996;278:573-81.